This event connects you with public and private payers for direct perspective into policy development and decision-making frameworks so you can successfully expand product coverage. Avoid pitfalls and improve market access through lessons learned, and collaborate on solutions during Q&A after peer-led case studies and success stories. Develop relationships with decision-makers as well as diagnostic industry peers in interactive discussion-based sessions. Through dynamic presentations from these commercial payer organizations as well as laboratories, test manufacturers, law firms and solution providers, learn in an intimate environment. Retain expert insights and address your individual questions on policy and coverage decisions so you can perfect your strategy to optimize reimbursement.

Read on q1productions.com

With NHS diagnostic services unable to keep pace with patient demand against the backdrop of ageing imaging equipment and radical structure reform, what market opportunities lie ahead for digital health suppliers and consultancies?

The move to unify clinical imaging through incoming imaging networks backed by £248m of regionwide investment represents a significant shift to improving the accuracy and faster turnaround times on tests and scans. To coincide with the launch of Digital Health Intelligence’s launch of Diagnostics and Clinical Imaging market intelligence service, we’re exploring the market movements, trust-level digital purchasing trends and predictions for the sector. Hear our expert team present analysis from Intelligence’s latest census-level NHS data across clinical imaging and provide comment on where next for the market.

Read on digitalhealth.net

Recent technological advances have made it possible for clinicians to quickly sequence the genomes of critically ill newborns and children to rapidly make a diagnosis. This powerful technology can transform lives by identifying potentially lifesaving and life-changing medical treatment. However, despite the enormous promise of genome sequencing to improve health outcomes, not all patients who might benefit from this technology can access it. This webinar will raise awareness about the clinical utility and lifesaving potential of clinical genome sequencing, as well as highlight coverage models for state Medicaid programs and private payors to help enable equitable access.

Read on nichd.nih.gov

We are proud to host Cambridge Healthtech Institute's Fourteenth Annual Next Generation Dx Summit which will take place in-person at the Grand Hyatt Washington, D.C. on August 22-24. The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care. Now in its fourteenth year, the Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important topics for the industry.

Read on nextgenerationdx.com

Digital data acquisition not only leads to better products from the dental laboratory, but to better processes for the patient and provider alike by building practice value throughout the treatment process.

Diagnostics are important for the detection and prevention of disease, determination of treatment effectiveness, and improvement in overall health outcomes. As diagnostics can be used to develop an individualized treatment plan or predict toxicity associated with a particular therapeutic, they are intimately associated with the field of personalized medicine.

Read on diaglobal.org

The Optical Society of America’s Fall Vision Meeting is a single-track, high-quality scientific conference focused on all aspects of the visual system. The 2021 meeting will be held at the University of Washington in Seattle, WA. Topics for this year’s meeting include:

• Artificial intelligence applications in ophthalmology and vision science
• GABAergic function and dysfunction in visual perception
• Reawakening plasticity in the visual cortex
• Retinal structure and function at the submicron resolutions
• Top-down and bottom-up approaches to computational modeling of vision
  
  Read on digitaldiagnostics.com

Over the last 16 years, South East Health Technologies Alliance (SEHTA) has developed an excellent reputation for support of its 1,400+ members, especially SMEs, through its one-to-one mentoring, fund-finding, consultancy and events programme.

In 2020, for the first time, SEHTA organised a major new international event; aimed at SME’s, Corporates, Academics & NHS Healthcare Providers, designed to take the programme of support to another level. We had 42 Sponsors and Exhibitors from all over the UK, Europe and Rest of the World and over 230 delegates take part.  Due to the COVID-19 restrictions we delivered the 2020 event virtually.

For 2021 we are aiming to run this event as a hybrid – a combination of a live & virtual event, to ensure the expo can be delivered to as many people as possible – an attended live event blended with the best elements and convenience of a digital one.  

Read on sehtamedtechexpo.co.uk

Static rule-based algorithms to assist medical diagnosis and treatment monitoring have been used in practice for decades (e.g. heart rate monitoring). Research into detecting epileptic seizures from the electrical activity of the brain , with machine learning, has been an active area of research for over 20 years. Given recent advancements in "big data", portable bio-sensing technologies, and other computer hardware/software, the feasibility of successfully implementing such algorithms into practice is improving.

This talk is an overview of how new applications of ML could soon provide physiologists with better quantitative tools to improve workflow and diagnostic accuracy. Prior knowledge of epilepsy, neuroscience, and ML is not assumed: talk aims to be accessible to a broad range of backgrounds.

Read on meetup.com